Related Experiment Videos
Haemarthrosis after superwarfarin poisoning
Panagiotis Kotsaftis1, Fotios Girtovitis, Afroditi Boutou
11st Department of Propedeutics in Internal Medicine, AHEPA Hospital, Aristotle University of Thessaloniki, Thessaloniki, Greece.
European Journal of Haematology
|July 28, 2007
Summary
Superwarfarin poisoning causes severe bleeding and requires prolonged, high-dose vitamin K treatment. This case highlights haemarthrosis as a rare complication of superwarfarin rodenticide ingestion.
Area of Science:
- Toxicology
- Hematology
Background:
- Superwarfarins are potent rodenticides causing prolonged bleeding disorders.
- Poisoning can lead to severe hemorrhage from multiple sites.
Observation:
- A 67-year-old male presented with melaena, epistaxis, and knee haemarthrosis after ingesting rodenticide.
- Initial treatments with blood products failed, with worsening coagulopathy (elevated PT, INR, aPTT).
- Diagnosis of superwarfarin poisoning was confirmed after patient admission of suicide attempt.
Findings:
- Superwarfarin poisoning necessitates prolonged, high-dose vitamin K therapy (30 mg daily for 4 months).
- Haemarthrosis is identified as a novel complication of superwarfarin poisoning.
- Normal mixing studies and liver function tests aided in diagnosing vitamin K-dependent clotting factor deficiency.
Implications:
- This case underscores the severity and prolonged nature of superwarfarin toxicity.
- Highlights the importance of considering superwarfarin poisoning in unexplained coagulopathies.
- Emphasizes the need for extended vitamin K treatment and recognition of rare complications like haemarthrosis.
Related Concept Videos
Anticoagulant Drugs: Low-Molecular-Weight Heparins
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
Venous Thrombosis III: Interprofessional Care
Venous thrombosis requires effective prevention and treatment strategies to improve patient outcomes and reduce potential complications.Prevention StrategiesHealthcare providers must prioritize preventing venous thromboembolism (VTE) for all adult patients upon admission. Interventions depend on bleeding and thrombosis risk, medical history, current medications, diagnoses, planned procedures, and patient preferences. Patients on bed rest should change positions every two hours and, if not...
Venous Thrombosis IV: Nursing Management
Nursing management begins with a thorough assessment of the patient's health history. Key factors include trauma to veins, peripherally inserted central catheters, varicose veins, recent pregnancy or childbirth, surgery, bacteremia, prolonged bed rest, atrial fibrillation, COPD, heart failure, cancer, coagulation disorders, myocardial infarction, spinal cord injury, stroke, prolonged travel, recent bone fractures, and dehydration. Review medication intake, particularly oral contraceptives,...
Disorders of Hemostasis
Hemostasis, the process that stops bleeding after a blood vessel injury, is crucial for maintaining the integrity of the circulatory system. However, disorders of hemostasis can disrupt this delicate balance, leading to either excessive clotting or bleeding. These disorders can be broadly classified into thromboembolic disorders and bleeding disorders.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Thromboembolic Disorders
Two factors primarily cause thromboembolic conditions.
Hemorrhagic Stroke ll: Pathophysiology
A hemorrhagic stroke develops when a cerebral blood vessel ruptures, allowing blood to escape into the surrounding brain tissue, as in intracerebral hemorrhage (ICH), or into the subarachnoid space, as in subarachnoid hemorrhage (SAH). Because the skull is a rigid compartment, the sudden presence of extravascular blood rapidly increases intracranial pressure and compresses adjacent neural structures, leading to immediate tissue injury and impaired cerebral perfusion.Mass Effect and Primary...
Anticoagulant Drugs: Vitamin K Antagonists and Direct Oral Anticoagulants
Oral anticoagulants are vital tools in preventing and treating blood clotting disorders. This diverse class of medications can be categorized as vitamin K antagonists, exemplified by warfarin, and direct thrombin inhibitors (DTIs), such as dabigatran, as well as factor Xa inhibitors, including rivaroxaban.
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...
Warfarin, a prominent vitamin K antagonist family member, exerts its effect by inhibiting the enzyme VKORC1 (vitamin K epoxide reductase complex 1). By hindering this enzyme, warfarin...